The Evolution of Pharmaceutical Research at the Interface of Academia and Industry
Andrew Dahlem (Lilly Research Laboratories)
Dr. Andrew Dahlem will present on the changing atmosphere of pharmaceutical research, fostering collaboration between industry and academia. Dr. Dahlem was named vice president and chief operating officer for Lilly Research Laboratories (LRL) and LRL Europe in February 2007. He previously served as vice president of toxicology, drug disposition, pharmacokinetics, and Lilly Research Laboratories in Europe since January 2003 and is a member of Lilly senior management. Dahlem serves as adjunct professor of toxicology in the College of Veterinary Medicine at Purdue University, the University of Illinois at Urbana-Champaign, and at The Ohio State University.
To learn more, visit here.
This seminar is hosted by the Veterinary and Biomedical Sciences as part of the Bortree Lecture Series.